PPARδ is a type 1 IFN target gene and inhibits apoptosis in T cells

Journal of Investigative Dermatology

Volumn 128, Issue 8, 2008, Pages 1940-1949

  Al Yacoub, Nadya ^a   Romanowska, Malgorzata ^a   Krauss, Sybille ^b   Schweiger, Susann ^b,c   Foerster, John ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; FAS ANTIGEN; FAS PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; BIOPSY; CELL PROLIFERATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN;

ANTIGENS, CD95; APOPTOSIS; BIOPSY; CELL PROLIFERATION; HUMANS; INTERFERON TYPE I; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PPAR DELTA; PSORIASIS; SIGNAL TRANSDUCTION; SKIN; T-LYMPHOCYTES;

EID: 47349101317     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.32     Document Type: Article

References (55)

1. Barish GD, Narkar VA, Evans RM (2006) PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest 116:590-7
2. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO (2004) Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med 199:731-6
3. Burdick AD, Bility MT, Girroir EE, Billin AN, Willson TM, Gonzalez FJ et al. (2007) Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes. Cell Signal 19:1163-71
4. Burdick AD, Kim DJ, Peraza MA, Gonzalez FJ, Peters JM (2006) The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. Cell Signal 18:9-20
5. Chang F, Jaber LA, Berlie HD, O'Connell MB (2007) Evolution of peroxisome proliferator-activated receptor agonists. Ann Pharmacother 41:973-83
6. Chinetti G, Fruchart JC, Staels B (2000) Peroxisome proliferator- activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49:497-505
7. Cippitelli M, Fionda C, Di Bona D, Lupo A, Piccoli M, Frati L et al. (2003) The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms. J Immunol 170:4578-92
8. Di-Poi N, Desvergne B, Michalik L, Wahli W (2005) Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins. J Biol Chem 280:38700-10
9. Di-Poi N, Michalik L, Tan NS, Desvergne B, Wahli W (2003) The anti-apoptotic role of PPARbeta contributes to efficient skin wound healing. J Steroid Biochem Mol Biol 85:257-65
10. Di-Poi N, Tan NS, Michalik L, Wahli W, Desvergne B (2002) Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 10:721-33
11. Dunlop TW, Vaisanen S, Frank C, Molnar F, Sinkkonen L, Carlberg C (2005) The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol 349:248-60
12. Dunn SE, Ousman SS, Sobel RA, Zuniga L, Baranzini SE, Youssef S et al. (2007) Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J Exp Med 204:321-30
13. Elder JT (2005) Psoriasis clinical registries, genetics, and genomics. Ann Rheum Dis 64(Suppl 2):ii106-7
14. Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R et al. (2001) Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 107:351-62
15. Gandarillas A, Goldsmith LA, Gschmeissner S, Leigh IM, Watt FM (1999) Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp Dermatol 8:71-9
16. Harris SG, Phipps RP (2001) The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. Eur J Immunol 31:1098-105
17. Harris SG, Phipps RP (2002) Induction of apoptosis in mouse T cells upon peroxisome proliferator-activated receptor gamma (PPAR-gamma) binding. Adv Exp Med Biol 507:421-5
18. He TC, Chan TA, Vogelstein B, Kinzler KW (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335-345
19. Hildeman DA, Zhu Y, Mitchell TC, Kappler J, Marrack P (2002) Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol 14:354-9
20. Hill EV, Sheppard CL, Cheung YF, Gall I, Krause E, Houslay MD (2006) Oxidative stress employs phosphatidyl inositol 3-kinase and ERK signalling pathways to activate cAMP phosphodiesterase-4D3 (PDE4D3) through multi-site phosphorylation at Ser239 and Ser579. Cell Signal 18:2056-69
21. Hobbs RM, Silva-Vargas V, Groves R, Watt FM (2004) Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions. J Invest Dermatol 123:503-15
22. Hu E, Kim JB, Sarraf P, Spiegelman BM (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274:2100-3
23. Icre G, Wahli W, Michalik L (2006) Functions of the peroxisome proliferator-activated receptor (PPAR) alpha and beta in skin homeostasis, epithelial repair, and morphogenesis. J Invest Dermatol 126:30-5
24. Jakobsen MA, Petersen RK, Kristiansen K, Lange M, Lillevang ST (2006) Peroxisome proliferator-activated receptor alpha, delta, gamma1 and gamma2 expressions are present in human monocyte-derived dendritic cells and modulate dendritic cell maturation by addition of subtype-specific ligands. Scand J Immunol 63:330-7
25. Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, Iversen L (2005) The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol 152:37-42
26. Jones DC, Ding X, Daynes RA (2002) Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent. J Biol Chem 277:6838-6845
27. Jones DC, Ding X, Zhang TY, Daynes RA (2003) Peroxisome proliferator-activated receptor alpha negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation. J Immunol 171:196-203
28. Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon H, Um JW et al. (2005) 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes. Exp Mol Med 37:179-85
29. Kimura R, Iwamoto R, Mekada E (2005) Soluble form of heparin-binding EGF-like growth factor contributes to retinoic acid-induced epidermal hyperplasia. Cell Struct Funct 30:35-42
30. Kohlmann WM, Urban W, Sterry W, Foerster J (2004) Correlation of psoriasis activity with abundance of CD25+CD8+ T cells: conditions for cloning T cells from psoriatic plaques. Exp Dermatol 13:607-12
31. Kostadinova R, Wahli W, Michalik L (2005) PPARs in diseases: control mechanisms of inflammation. Curr Med Chem 12:2995-3009
32. Kuenzli S, Saurat JH (2003) Effect of topical PPARbeta/delta and PPARgamma agonists on plaque psoriasis. A pilot study. Dermatology 206:252-6
33. Letavernier E, Perez J, Joye E, Bellocq A, Fouqueray B, Haymann JP et al. (2005) Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure. J Am Soc Nephrol 16:2395-402
34. Liou JY, Lee S, Ghelani D, Matijevic-Aleksic N, Wu KK (2006) Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 26:1481-7
35. Lowes MA, Chamian F, Abello MV, Fuentes-Duculan J, Lin SL, Nussbaum R et al. (2005) Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 102:19057-62
36. Maisch B, Richter A, Sandmoller A, Portig I, Pankuweit S (2005) Inflammatory dilated cardiomyopathy (DCMI). Herz 30:535-44
37. Malhotra S, Bansal D, Shafiq N, Pandhi P, Kumar B (2005) Potential therapeutic role of peroxisome proliferator activated receptor-gamma agonists in psoriasis. Expert Opin Pharmacother 6:1455-61
38. Maroteaux L, Chen L, Mitrani-Rosenbaum S, Howley PM, Revel M (1983) Cycloheximide induces expression of the human interferon beta 1 gene in mouse cells transformed by bovine papillomavirus-interferon beta 1 recombinants. J Virol 47:89-95
39. Marrack P, Kappler J (2004) Control of T cell viability. Annu Rev Immunol 22:765-87
40. Marrack P, Kappler J, Mitchell T (1999) Type I interferons keep activated T cells alive. J Exp Med 189:521-30
41. Pesant M, Sueur S, Dutartre P, Tallandier M, Grimaldi PA, Rochette L et al. (2006) Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis. Cardiovasc Res 69:440-9
42. Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM, Hatae T et al. (2006) Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 27:63-9
43. Rahman P, Elder JT (2005) Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis 64(Suppl 2):ii37-9; discussion ii40-1
44. Ringold GM, Dieckmann B, Vannice JL, Trahey M, McCormick F (1984) Inhibition of protein synthesis stimulates the transcription of human beta-interferon genes in Chinese hamster ovary cells. Proc Natl Acad Sci USA 81:3964-8
45. Romanowska M, Al-Yacoub N, Seidel H, Donandt S, Gerken H, Haritonova N et al. (2008) PPAR delta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor. J Invest Dermatol 128:110-24
46. Shirakata Y, Kimura R, Nanba D, Iwamoto R, Tokumaru S, Morimoto C et al. (2005) Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci 118:2363-2370
47. Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM et al. (2003) The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci USA 100:9968-73
48. Soller M, Tautenhahn A, Brune B, Zacharowski K, John S, Link H et al. (2006) Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis. J Leukoc Biol 79:235-43
49. Sprecher DL, Massien C, Pearce G, Billin AN, Perlstein I, Willson TM et al. (2007) Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist. Arterioscler Thromb Vasc Biol 27:359-65
50. Tan NS, Michalik L, Di-Poi N, Ng CY, Mermod N, Roberts AB et al. (2004) Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression. EMBO J 23:4211-21
51. Tan NS, Michalik L, Noy N, Yasmin R, Pacot C, Heim M et al. (2001) Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev 15:3263-77
52. Tanabe Y, Nishibori T, Su L, Arduini RM, Baker DP, David M (2005) Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J Immunol 174:609-13
53. Westergaard M, Henningsen J, Johansen C, Rasmussen S, Svendsen ML, Jensen UB et al. (2003) Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. J Invest Dermatol 121:1104-17
54. Yacoub NA, Romanowska M, Haritonova N, Foerster J (2007) Optimized production and concentration of lentiviral vectors containing large inserts. J Gene Med 9:579-84
55. Zheng Y, Peng Z, Wang Y, Tan S, Xi Y, Wang G (2003) Alteration and significance of heparin-binding epidermal-growth-factor-like growth factor in psoriatic epidermis. Dermatology 207:22-7